Papewalis C, Jacobs B, Wuttke M, Schott M
Department of Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany.
Exp Clin Endocrinol Diabetes. 2008 Sep;116 Suppl 1:S33-9. doi: 10.1055/s-2008-1081489. Epub 2008 Sep 5.
Currently, no curative therapies are available for many malignant diseases and for autoimmune disorders. Over the past two decades, however, substantial progress has been made in our understanding of immunity and immune tolerance. Numerous of immune mechanisms were identified responsible for breaking the state of tolerance and for inducing specific cytotoxic immunity. In parallel, much knowledge has been gained on how immune tolerance can be re-induced in autoimmune diseases. Here, we would like to add value to the current advances in cellular therapy for treating endocrine cancer as well as for inducing immune tolerance in autoimmune diseases. In addition, new insights into stem cell research in autoimmune diseases are presented and future perspectives are given.
目前,许多恶性疾病和自身免疫性疾病尚无治愈性疗法。然而,在过去二十年中,我们对免疫和免疫耐受的理解取得了重大进展。已确定许多免疫机制负责打破耐受状态并诱导特异性细胞毒性免疫。与此同时,对于如何在自身免疫性疾病中重新诱导免疫耐受也有了很多了解。在此,我们希望为当前细胞疗法在治疗内分泌癌以及在自身免疫性疾病中诱导免疫耐受方面的进展增添价值。此外,还介绍了自身免疫性疾病干细胞研究的新见解并给出了未来展望。